Delandistrogene moxeparvovec, sold under the brand name Elevidys, is a recombinant gene therapy used for the treatment of Duchenne muscular dystrophy. From Wikipedia
The review underscores limited clinical efficacy, significant safety risks, and financial barriers associated with delandistrogene moxeparvovec.
